These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17424834)

  • 1. Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV.
    Attallah AM; Mosa TE; Omran MM; Abo-Zeid MM; El-Dosoky I; Shaker YM
    J Immunoassay Immunochem; 2007; 28(2):155-68. PubMed ID: 17424834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.
    Attallah AM; Toson EA; Shiha GE; Omran MM; Abdel-Aziz MM; El-Dosoky I
    J Immunoassay Immunochem; 2007; 28(3):199-211. PubMed ID: 17613667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
    El-Mezayen HA; Habib S; Marzok HF; Saad MH
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis].
    Guo JX; Ma HB; Li YL; Xu J; Yang LH; Shi JB; Li B; Liu AX; Li XX; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):71-3. PubMed ID: 19799025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.
    Attallah AM; Zahran F; Ismail H; Omran MM; El-Dosoky I; Shiha GE
    J Immunoassay Immunochem; 2007; 28(4):331-42. PubMed ID: 17885887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
    Chen YP; Feng XR; Dai L; Ding HB; Zhang L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
    Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
    Leonardi S; La Spina M; La Rosa M; Schilirò G
    Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG; Luo CY; Wu SM; Wang CL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infection.
    Berres ML; Schlosser B; Berg T; Trautwein C; Wasmuth HE
    J Clin Gastroenterol; 2012 Apr; 46(4):334-8. PubMed ID: 21934527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of tissue inhibitor of metalloproteinase-1 are correlated with liver fibrosis in patients with chronic hepatitis B.
    Zhu CL; Li WT; Li Y; Gao RT
    J Dig Dis; 2012 Nov; 13(11):558-63. PubMed ID: 23107442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection.
    Attallah AM; Toson el-SA; El-Waseef AM; Abo-Seif MA; Omran MM; Shiha GE
    Clin Chim Acta; 2006 Jul; 369(1):66-72. PubMed ID: 16545356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.